November 2006 Issue of MMM
It's game seven of the National League Championship Series and the New York Mets, down two runs in the bottom of the 9th, have runners ...
Merck has taken the high-tech route to improving efficiency in the field, while other firms experiment with promising new approaches to targeting and detailing physicians.
Biotechs that combine forces with well-established big pharma companies can benefit from added credibility to the rep and sales force resources. Creating partnerships with big ...
Sales reps wouldn't be effective without the proper training in product knowledge and building relationships with doctors. Pharma companies are realizing that education should be ...
A state law banning commercial use of prescription audit data is meant to protect physicians' privacy. But its effects on industry could be potentially damaging, ...
For the majority medical/surgical and specialty journal publishers, there was little respite during the first half of 2006. PERQ/HCI's Eugene M. May reports on the ...
Novartis Pharmaceuticals Corp., the US arm of Swiss firm Novartis AG, is launching four new drugs over the next year.
Although barely a year has passed since Pfizer ushered in the era of the downsized sales operation with the announcement that it would cut its ...
Two decades ago, back when I was a resident in the hospital trenches treating AIDS patients with little more than the anti-viral AZT and hope, ...
Thought the question of consumer advertising was settled with PhRMA's DTC guidelines? Think again.
Med Ed Report
The most innovative feature of a code that went into effect last month at Stanford University, says one of the its architects, is the extension ...
ACCME revamped its accreditation model, giving providers until 2008 to comply.
Funding for medical education next year will likely increase or remain stable, according to a Cutting Edge Information survey.
Wyeth gave a $500,000 block grant to the Medical Association of Georgia to be shared by accredited providers.
Outcomes Inc.'s 2006 study found that dinner meetings have a somewhat low educational impact.
Quadrant Medical Education has hired Alison Gale as director of new business development, with responsibility for Quadrant's medical education and The Female Patient.
International Federation of Pharmaceutical Manufacturers & Associations adopted a code regarding the organization of international educational events, company sponsorship, provision of hospitality and entertainment, and ...
An analysis in JAMA co-written by Dave Davis, MD, suggests physicians' self-assessment of competence is not very accurate.
Thomson is buying the balance of Solucient from media giant VNU, private equity firm Veronis Suhler Stevenson and healthcare provider alliance VHA.
MediMedia USA has changed hands as a private equity consortium. Ciniven, Apax Partners and The Carlyle Group agreed to sell the publisher to New York-based ...
Ex-JAMA publisher Peter Murphy and former Medical Economics publisher Stuart Williams are collaborating on a new venture, Braveheart Publishing.
Quadrant HealthCom launched Urgent Care, the official journal of the American Academy of Urgent Care Medicine.
Nature Clinical Practice is partnering with Mrvica Associates for US advertising on Nature Clinical Practice Gastroenterology & Hepatology.
John Wiley & Sons acquired Clinical Cardiology and Scanning from the Clinical Cardiology Publishing Company and the Foundation for Advances in Medicine and Science.
Companies have been using combative advertising since long before Boniva v. Actonel.
Looking for credible health information on the Internet is getting much easier, if you know where and how to look for it.
Medical Broadcasting Company (MBC) has tapped the former online chief of urban marketing giant, Black Entertainment Television, to lead its growing technology team.
Thomson has relaunched its Physicians Desk Reference portal, PDR.net, adding a new messaging tool for pharma marketers to target prescribers.
Lita Sands, who once headed CRM at Pfizer, has been hired by Ogilvy Healthworld as client services strategy head in its Healthcare unit.
Novartis is boosting its sales force size ahead of anticipated drug launches, the industry trade group, the National Association of Pharmaceutical Sales Representatives (NAPSR) said.
GlaxoSmithKline said it would not renew its 2007 sales engagement with contract sales firm PDI.
SK&A Information Services has hired direct marketing veteran Tom McCulloh to represent the firm to list brokers nationally.
MicroMass Communications has named Phil Stein chief operating officer, Cheryl Nigro, senior vice president, new business development and Michael Berliner as associate creative director.
Direct marketing pioneer Lester Wunderman made his blogging debut with the launch of The Lester Chronicles at Wunderman.com where the agency's chairman emeritus will explore ...
Valassis won a Web Marketing Association WebAward for its work on the In Step with Synvisc Web site and relationship marketing program for client Genzyme.
Bristol-Myers Squibb said it plans to expand DTC advertising for Plavix as it seeks to mitigate the impact of the recent generic clopidigrel launch.
The Division of Drug Marketing, Advertising & Communication (DDMAC) has added a second DTC review group to meet soaring demand for advertising approvals, said DTC ...
A New Zealand activist group joined the anti-DTC advertising pile-on, urging its ouster by the end of 2006.
CCA Advertising hired former JWT and Y&R creative chief Helayne Spivak as chief creative officer.
Schering-Plough released the latest installment of its Nasonex "Bee" series, this time with a retooled message promising multi-symptom relief to allergy sufferers and a new ...
About.com snapped up Calorie-Count.com, a weight loss site that generates 24 million page views from 464,109 unique users per month, from AeroDiet.com, LLC.
In the wake of the Vioxx litigations, the media and public are in a frenzy questioning the safety of widely used pharmaceutical drugs and the ...
Hill & Knowlton named GCI Group's AnnaMaria DeSalva to head its worldwide healthcare practice.
AstraZeneca named the AARP's Lisa Davis, a long-time Washington communications hand, to head all internal and external corporate communications in the US.
To show, or not to show?
"Prior to 1990, most prosecutions for violations of the Federal Food, Drug, and Cosmetic Act (FDCA), were for misdemeanors; since, the most common charges brought ...
Former FDA deputy commissioner for policy Michael Taylor says the agency lacks the legal authority and financial and staff resources it needs to properly regulate ...
A significant effort by FDA is now in "the planning stage," designed to determine how patients, physicians and other healthcare providers obtain information about emerging ...
An initial report by the Pharmaceutical Research and Manufacturers of America (PhRMA) Office of Accountability says that all companies that have signed the group's "Guiding ...
DDMAC says two promotional pieces for Reliant Pharmaceuticals' Rythmol SR were false or misleading because they failed to include any risk information and they broadened ...
The FDA has approved a revised medication guide and labeling for Bristol-Myers Squibb's blood thinner Coumadin (warfarin sodium) to more prominently emphasize a warning about ...
A Bayer admission that it "mistakingly" did not submit new risk information to the FDA on antibleeding drug Trasylol underscores the agency's struggle to get ...
After 13 years in public advocacy for the American Pharmacists Association (APhA), attorney Susan C. Winckler has moved to FDA’s Office of Policy and Planning ...
"Not as good as we'd hoped" is the reaction by the FDA to early efforts by manufacturers to prepare Rx drug labels in conformance with ...
Imagine (we all have bad dreams from time to time) that you’ve been appointed FDA Commissioner.
- Guidemark Health merges with three companies to form new agency
- Five things for pharma marketers to know: Monday, October 17, 2016
- Five things for pharma marketers to know: Thursday, October 20, 2016
- Five things for pharma marketers to know: Friday, October 14, 2016
- Five things for pharma marketers to know: Tuesday, October 18, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy
- Five things for pharma marketers to know: Friday, October 21, 2016
- Trump or Clinton? Either May Lead to Better Mental Healthcare
- Five things for pharma marketers to know: Thursday, October 20, 2016
- Why Excedrin embraced the headache of a contentious election season
- StartUp Health reports more global deals, uptick in pharma investment in digital health